Chirurgia Urologica Robotica Mininvasiva e dei Trapianti Renali, Azienda Ospedaliero-Universitaria Careggi, 9300Università di Firenze, Italy.
Dipartimento della donna, 18994del bambino e di chirurgia generale e specialistica. Università della Campania "Luigi Vanvitelli", Italy.
Surg Innov. 2021 Dec;28(6):723-730. doi: 10.1177/1553350621995042. Epub 2021 Feb 18.
Post-prostatectomy stress urinary incontinence (PPSUI) is one of the major complaints after radical prostatectomy. Transoburator male sling (TMS) placement is indicated in persistent mild to moderate PPSUI. External beam radiation therapy (EBRT) might be a negative prognostic factor for TMS outcomes. Study objective was to analyze EBRT impact on TMS outcome. We retrospectively investigated patients submitted to TMS for PPSUI, with or without previous EBRT, in two tertiary referral centers since 2010. Objective outcome was measured through ICIQ-SF, 1-hour pad test, and pad per die and subjective improvement through PGI-I. Patients were divided according to EBRT to make in-group and between-group comparisons. Patients were 56, 18 (32.1%) had previous EBRT. Median follow-up was 43.0 months (IQR: 22.3-64.0). TMS was placed at mean 18.8 months (SD 4.6) after EBRT. TMS determined a statistically significant reduction of pads, 1-hour pad test, and ICIQ-SF score (<.05). Improvement diminished during long-term follow-up. At last follow-up, 12 patients (21.4%) used 1 safety pad, while 15 (26.8%) used 0 pads. Median PGI-I was 2 (IQR 2-3). Recorded complications were 9 (16.1%) and none exceeded Clavien-Dindo grade 2. There were no differences in outcomes, failures, and complications between groups. TMS failures were 6 (10.7%), 2 of whom in the EBRT group. Four of them (7.1%) subsequently placed an artificial urinary sphincter (AUS). . Advance XP© placement seems effective and safe in well-selected patients complaining with PPSUI, even after EBRT. Surgical outcomes slightly deteriorate over time. Further studies are needed in these patients to assess TMS efficacy.
前列腺根治术后尿失禁(PPSUI)是前列腺根治术后的主要并发症之一。对于持续存在轻度至中度 PPSUI 的患者,可考虑采用经耻骨后男性吊带(TMS)置入术。外照射放疗(EBRT)可能是 TMS 治疗结果的一个负面预后因素。本研究旨在分析 EBRT 对 TMS 治疗结果的影响。
我们回顾性分析了 2010 年以来在两个三级转诊中心因 PPSUI 接受 TMS 治疗的患者,这些患者中有些患者之前接受过 EBRT。通过国际尿失禁咨询委员会尿失禁问卷简表(ICIQ-SF)、1 小时尿垫试验和每日尿垫使用量评估客观治疗效果,通过患者总体印象改善量表(PGI-I)评估主观改善情况。根据是否接受 EBRT 将患者分为 EBRT 组和非 EBRT 组,进行组内和组间比较。
患者的平均年龄为 56 岁,18 例(32.1%)患者有 EBRT 治疗史。中位随访时间为 43.0 个月(IQR:22.3-64.0)。EBRT 后平均 18.8 个月(SD:4.6)时行 TMS 治疗。TMS 治疗可显著减少尿垫使用量、1 小时尿垫试验和 ICIQ-SF 评分(<0.05)。在长期随访过程中,治疗效果逐渐减弱。末次随访时,12 例患者(21.4%)使用 1 个安全尿垫,15 例患者(26.8%)无需使用尿垫。PGI-I 中位数为 2(IQR:2-3)。记录到 9 例(16.1%)并发症,均未超过 Clavien-Dindo 分级 2 级。两组在治疗效果、失败率和并发症方面无差异。TMS 治疗失败 6 例(10.7%),其中 2 例患者在 EBRT 组。4 例患者(7.1%)随后行人工尿道括约肌(AUS)置入术。在精心选择的 PPSUI 患者中,即使在 EBRT 治疗后,Advance XP© 吊带系统也具有良好的治疗效果和安全性。手术效果随时间推移逐渐恶化。需要对这些患者进行进一步研究,以评估 TMS 的疗效。